Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 15;14(3):642.
doi: 10.3390/pharmaceutics14030642.

Antimicrobial Peptides as an Alternative for the Eradication of Bacterial Biofilms of Multi-Drug Resistant Bacteria

Affiliations
Review

Antimicrobial Peptides as an Alternative for the Eradication of Bacterial Biofilms of Multi-Drug Resistant Bacteria

Janaína Teixeira Costa de Pontes et al. Pharmaceutics. .

Abstract

Bacterial resistance is an emergency public health problem worldwide, compounded by the ability of bacteria to form biofilms, mainly in seriously ill hospitalized patients. The World Health Organization has published a list of priority bacteria that should be studied and, in turn, has encouraged the development of new drugs. Herein, we explain the importance of studying new molecules such as antimicrobial peptides (AMPs) with potential against multi-drug resistant (MDR) and extensively drug-resistant (XDR) bacteria and focus on the inhibition of biofilm formation. This review describes the main causes of antimicrobial resistance and biofilm formation, as well as the main and potential AMP applications against these bacteria. Our results suggest that the new biomacromolecules to be discovered and studied should focus on this group of dangerous and highly infectious bacteria. Alternative molecules such as AMPs could contribute to eradicating biofilm proliferation by MDR/XDR bacteria; this is a challenging undertaking with promising prospects.

Keywords: MDR bacteria; antimicrobial peptides; antimicrobial resistance; biofilm; drug discovery; extensive drug resistance.

PubMed Disclaimer

Conflict of interest statement

All contributing authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Basic and general aspects of biofilm formation (upper section) and brief description of the mechanisms action of antimicrobial peptides (AMPs) (lower section).

References

    1. WHO . Critically Important Antimicrobials for Human Medicine: Ranking of Antimicrobial Agents for Risk Management of Antimicrobial Resistance due to Non-Human Use. 5th ed. World Health Organization; Geneva, Switzerland: 2017.
    1. Sultan I., Rahman S., Jan A.T., Siddiqui M.T., Mondal A.H., Haq Q.M.R. Antibiotics, resistome and resistance mechanisms: A bacterial perspective. Front. Microbiol. 2018;9:2066. doi: 10.3389/fmicb.2018.02066. - DOI - PMC - PubMed
    1. Gedefie A., Demsis W., Ashagrie M., Kassa Y., Tesfaye M., Tilahun M., Bisetegn H., Sahle Z. Acinetobacter baumannii Biofilm Formation and Its Role in Disease Pathogenesis: A Review. Infect. Drug Resist. 2021;14:3711. doi: 10.2147/IDR.S332051. - DOI - PMC - PubMed
    1. Magana M., Pushpanathan M., Santos A.L., Leanse L., Fernandez M., Ioannidis A., Giulianotti M.A., Apidianakis Y., Bradfute S., Ferguson A.L., et al. The value of antimicrobial peptides in the age of resistance. Lancet Infect. Dis. 2020;20:e216–e230. doi: 10.1016/S1473-3099(20)30327-3. - DOI - PubMed
    1. Vestby L.K., Grønseth T., Simm R., Nesse L.L. Bacterial Biofilm and its Role in the Pathogenesis of Disease. Antibiotics. 2020;9:59. doi: 10.3390/antibiotics9020059. - DOI - PMC - PubMed

LinkOut - more resources